9月21日至23日，第十七届全国营养科学大会在北京隆重开幕。作为国内营养健康领域的顶级盛会，本 届大会以"营养创新·推动全民健康高质量发展"为主题，汇聚了众多权威学者与行业领袖，共商营养科 学前沿议题，成为助推"健康中国2030"战略落地的学术与产业双引擎。 值得一提的是，该研究成果已发表于营养学顶级期刊《Nutrients》，其科学价值获得国际学术界认可。 全球研发布局，铸就品牌核心竞争力 据品牌介绍，inne在科研层面的积累和突破并非偶然，而是依托于长期构建的全球化研发体系。品牌先 后在中国、美国、德国及意大利建立了五大研发中心，并在亚洲设立了2300平米的功效验证与检测实验 室，并通过CNAS国家实验室认证，为临床研究和产品验证提供了可靠保障。 此次学术盛宴上，源自德国的儿童营养品牌inne（中文名：因你）凭借卓越的科研实力和创新成果成为 焦点。在大会婴幼儿营养分论坛上，inne携手沈阳药科大学中药学院副院长韩娜教授带来竹节钙专利成 分Kidtal 的科究成果分享，以扎实的实证数据和创新理念，获得与会专家的关注与好评。 临床实证，树立科学营养的"金标准" 展会期间，inne因你以"临床实证是科学营养金标 ...

9月20日，德国萨尔布吕肯会议大厅内热闹非凡，一场别开生面的乒乓球趣味挑战赛精彩上演。欧洲乒 坛劲旅萨尔布吕肯乒乓球俱乐部（1. FC Saarbrücken TT）派出豪华阵容，队长帕特里克·弗朗西斯卡、 世界名将达科·约奇克携手新加盟的中国奥运冠军闪亮登场。选手们与观众零距离互动，现场切磋球 技，气氛持续升温，掌声与欢呼不断。 此次活动由德国知名儿童营养品牌inne（中文名：因你）与萨尔布吕肯乒乓球俱乐部（1.FC Saarbrücken TT）联合发起，以"Ping Pong for Love"为主题，旨在通过趣味乒乓挑战汇聚爱心，为FCS乒乓球青训俱 乐部的年轻运动员培养及南非开普敦"Inspire Land"公益设施建设募集善款，传递体育与健康共进的公益 理念。 乒乓球台上，爱心跃动 本次"Ping Pong for Love"公益赛设有接发球挑战赛、目标发球赛和拉力对抗赛三大互动环节。首轮接发 球挑战赛中，帕特里克·弗朗西斯卡、达科·约奇克与中国奥运冠军携手迎战30名现场观众。每一次挑战 成功均触发inne品牌捐赠，最终为FCS乒乓球青训俱乐部筹得2600欧元，用于改善青少年训练环境。 萨尔布吕肯 ...

展会现场，inne因你带来了其全系产品矩阵，包括助力儿童骨骼发育的分龄钙营养系列、聚焦眼脑发育的分龄护 眼及DHA产品系列，以及提升免疫力的多维营养与益生菌·专研系列等，吸引了来自德国及欧洲各地的药剂师、医 疗健康专业人士及渠道代表驻足交流。 "在德国，药房渠道对产品的安全性和有效性有着近乎苛刻的要求。"一位来自杜伊斯堡的药剂师在参观后表 示，"inne提供的临床验证数据和制药级研发理念，与我们专业药房的需求高度契合。" 9月16日，国际医药行业迎来年度盛事——欧洲极具权威的德国医药及制药展览会（expopharm 2025）在杜塞尔多 夫会展中心正式拉开帷幕。本届展会汇聚了来自药品、营养补充剂、医疗器械及数字健康等全产业链的众多参与 者，其严格的资质审核体系确保了展商的高质量与产品的专业性。作为国际制药工业的重要枢纽，expopharm已成 为行业巨头发布创新产品和领先科研成果的关键舞台，持续引领着欧洲医药市场的未来趋势。 值得注意的是，今年展会迎来一家特殊展商——来自德国的儿童营养品牌inne（中文名：因你）。作为少数亮相 该展会的专业儿童营养品牌，inne因你的参展被视为儿童营养品迈向"制药级、科学化、 ...

"我把光明捧在手中，照亮每一个人的脸庞。"这句出自眼健康领域的领军人——陶勇教授的诗句，凝练 了他"天下无盲"的医学理想和从医二十余年来的温暖坚守。 如今，这份关于光明的守护有了新的注脚。近日，陶勇教授受邀担任儿童营养品牌inne 因你的"科学护 眼首席顾问"，双方将基于陶勇在眼科临床前沿的深刻洞察，与inne 因你儿童科学营养领域的科研实 力，共同探索医学与营养的协同路径，开辟科学护眼新阵地，从源头守护下一代的"光明未来"。 护眼，关乎一代人健康质量的"必答题" 当前，中国儿童的视力健康正面临严峻挑战。国家卫健委公布的数据显示，我国儿童总体近视率已达 51.9%，其中高中生近视率高达81.2%。更值得警惕的是，近视高发年龄段已从8—12岁提前至6—10 岁。儿童近视低龄化、高发化的趋势日益显著，已成为关乎国民健康素质的重要公共卫生议题。 科学营养，守护成长的第一道光线 此次陶勇携手inne 因你，源于双方在儿童护眼理念上的高度共鸣。陶勇一直强调，护眼应成为生活里 的"基础操作"，要从营养补充抓起，为孩子的视觉健康打下坚实基础。这与inne 因你"为宝宝打下一生 健康基础"的品牌初心不谋而合。 据了解，作为源 ...

Core Insights - The article highlights the increasing importance of clinical research and scientific data in the selection of children's nutritional products by parents [1][2] - Inne has made significant advancements in clinical projects through its Institute of Nutrition and Health, collaborating with various research institutions to validate the efficacy of its selected ingredients [1] - Recent research on Inne's DHA supplementation has shown improvements in memory in mice, with results published in the authoritative journal eFood, indicating the scientific credibility of the findings [1][2] Group 1 - Inne's recent academic conference focused on the clinical evidence of calcium supplementation, showcasing its commitment to scientific innovation in the children's nutrition sector [2] - The company has previously published research on its patented Kidtal ingredient, which enhances bone density and strength, in the well-known journal Nutrients [2] - Inne aims to transition the industry from experience-driven practices to evidence-based approaches, emphasizing the importance of rigorous clinical research in children's nutrition [2] Group 2 - The challenges of conducting clinical research in children's nutrition, including long research cycles and individual variability, are acknowledged as critical for industry advancement and consumer trust [2] - Inne plans to continue building a product matrix based on evidence-based medicine, translating cutting-edge research into practical health support for consumers [2] - The company aspires to define the "gold standard" in children's nutrition through clinical evidence, providing better nutritional choices for parents and children [2]

在儿童生长发育的黄金期，科学补钙关乎一生的健康基石。然而现实不容乐观：儿童钙摄入普遍不足，补钙误区丛生，家长们面对五花八门的补钙 产品往往陷入选择焦虑，行业亟需建立科学选钙的"黄金标准"。 在此背景下，一场具有里程碑意义的学术会议应运而生。源自德国的儿童营养品牌inne因你，携手CBME、央视网发起"临床实证：跨时代科学补 钙"学术会议，邀请上海交通大学附属新华医院营养科主任冯一、中国福利会国际和平妇幼保健院儿保科主任医师余文、中国医科大学附属第四医院 副教授张又夕、CBME总经理刘勋、inne德国技术顾问施迈策博士、inne营养健康研究院（inne Institude of Nutrition and Health）执行院长周正圆博 士，抖音头部达人@带娃的小璐等各领域权威专家与行业领袖，就"临床实证推动行业跨入效果革命新时代"的重要意义展开深入探讨。 作为行业首个系统推进临床验证的品牌，inne此举打响了儿童营养行业"临床实证的第一枪"，不仅获得了业内专家学者的高度认可，更赢得了央视 网、中新网、消费日报等权威媒体，及母婴行业观察、新浪育儿、中童观察等行业媒体的广泛关注与报道。这一里程碑式的会议，标志着儿 ...

Core Viewpoint - The article discusses the participation of various international brands at the China International Import Expo (CIIE), highlighting their strategies for market expansion and localization in China, which is seen as a critical market for global growth [1][3][12]. Group 1: Brand Strategies and Market Expansion - CASETiFY views China as a core market in its global strategy, planning to increase both online and offline investments while expanding its product range [3][4]. - Sony has redefined itself as a creative entertainment company and is leveraging the CIIE to enhance its brand presence and connect with local governments and industry chains [5][12]. - Sonova aims to tap into the growing Chinese market for hearing health solutions, expecting double-digit growth and showcasing innovative products at the expo [7][12]. Group 2: Success Stories from Previous Expos - Nippon Paint transitioned from a new participant to an established player, achieving significant contracts and showcasing systemic solutions at this year's expo [8][9]. - MSC Cruises continues to strengthen its presence in China, aiming to attract global tourists while promoting local employment and consumption [9][12]. - The German children's nutrition brand inne emphasizes the importance of adapting to local consumer needs through clinical research and partnerships with local institutions [10]. Group 3: Investment and Localization Efforts - Straumann is investing heavily in China, with a new manufacturing facility expected to generate significant revenue and employment opportunities [13]. - Nippon Paint is expanding its production capacity in Tianjin, reflecting its commitment to the Chinese market [14]. - Wartsila is experiencing strong demand in China, with its Shanghai facility operating at full capacity and contributing to global shipping industry advancements [15][16].

Group 1: Impact of the China International Import Expo (CIIE) - The CIIE serves as a comprehensive platform for international brands to connect with local governments and supply chains, enhancing brand visibility and business opportunities [1][4] - The eighth CIIE is expected to showcase a growing number of international brands, reflecting the event's expanding influence and the ongoing relationship between new and returning exhibitors [1][3] Group 2: Company Strategies and Market Focus - CASETiFY views China as a core market in its global strategy, planning to increase both online and offline investments while expanding its product range [3] - Sony has redefined itself as a creative entertainment company and is significantly increasing its exhibition space at the CIIE to showcase diverse business segments [5] - Sonova aims to leverage the CIIE to penetrate the Chinese market more deeply, with plans for high double-digit growth driven by an aging population and increased awareness of hearing health [6] Group 3: Local Partnerships and Product Innovations - Inne is focusing on local partnerships and clinical research to adapt its products to meet the needs of Chinese consumers, highlighting the importance of scientific backing in product development [8] - Swiss pump manufacturer Aeg Pump is enhancing its localization strategy, increasing its revenue share in China from 15% to 20% [8] Group 4: Investment and Growth in China - Straumann is investing in a high-end implant production facility in Shanghai, reflecting its commitment to the Chinese market and the anticipated annual revenue of 1.4 billion RMB [11] - The semiconductor industry in China is experiencing rapid growth, with companies like Panshi planning to expand production capacity to meet increasing demand [12] - Wärtsilä is capitalizing on strong demand in China, with its Shanghai facility operating at full capacity and serving as a key production base for dual-fuel engines [12]

Core Viewpoint - The article emphasizes the importance of "clinical validation" as a key standard for assessing the quality of children's health products, particularly calcium supplements, in the context of evolving scientific parenting concepts [1][4]. Group 1: Industry Developments - The CBME International Pregnancy, Baby, and Child Exhibition in Shanghai showcased the German children's nutrition brand inne, which launched a comprehensive clinical validation system for children's nutrition [1][3]. - Inne is leading a revolution in the industry by transitioning from "experience-driven" to "scientific evidence" in children's nutrition, establishing a new benchmark for product efficacy verification [2][11]. - The academic conference highlighted the shift in the industry towards clinical evidence as the core principle for children's nutritional supplements, marking a new era in the sector [1][11]. Group 2: Clinical Research and Findings - Clinical research conducted by inne in collaboration with various prestigious medical institutions has demonstrated the effectiveness of their calcium products, particularly the patented ingredient Kidtal, in promoting children's growth and bone health [5][7]. - The research findings have been published in the top-tier nutrition journal "Nutrients," indicating international academic recognition of the scientific validity and effectiveness of inne's products [5][6]. - Experts at the conference emphasized the necessity of clinical validation as the "gold standard" for assessing the safety and efficacy of calcium supplements for children [4][7]. Group 3: Future Directions - Inne plans to continue its commitment to scientific innovation and deepen its exploration of clinical validation, aiming to provide safer, more effective, and precise nutritional solutions for children's health [12]. - The establishment of the inne Institute of Nutrition and Health signifies a new phase in the company's efforts to integrate cutting-edge research into practical products for consumers [8][10].

Core Viewpoint - The article emphasizes the importance of "clinical validation" as a critical standard for evaluating children's health products, particularly calcium supplements, in the context of evolving scientific parenting concepts [1][6]. Group 1: Industry Trends - The children's nutrition industry is transitioning from "experience-driven" to "evidence-based" approaches, with a focus on clinical validation to establish new standards for calcium supplementation [3][14]. - Over 50% of calcium supplements in the market are still basic forms like calcium carbonate and lactate, with only 15% having undergone clinical trials, indicating a significant gap in scientific validation [4][6]. Group 2: Company Initiatives - Inne, a German-origin children's nutrition brand, has launched a comprehensive clinical validation system and hosted an academic conference titled "Clinical Validation: A Revolutionary Approach to Scientific Calcium Supplementation" [1][3]. - The company has established global research centers in Germany, China, Australia, and the USA, focusing on high-absorption, preservative-free nutritional products [4][11]. Group 3: Clinical Research and Findings - Clinical studies conducted in collaboration with reputable institutions have shown that Inne's proprietary ingredient, Kidtal, significantly promotes growth and bone health in children aged 2-12 [7][8]. - Research published in the international journal "Nutrients" has validated the effectiveness of Kidtal, enhancing its credibility in the scientific community [8][9]. Group 4: Future Directions - Inne plans to continue its commitment to scientific innovation and deepen clinical research collaborations to provide safer, more effective nutritional solutions for children's health [15].